CLINICAL RESEARCH: ATHEROSCLEROSIS
Elevated Levels of VE-Cadherin-Positive Endothelial Microparticles in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
Hidenobu Koga, MD*,
Seigo Sugiyama, MD, PhD*,*,
Kiyotaka Kugiyama, MD, PhD ,
Keisuke Watanabe, MD*,
Hironobu Fukushima, MD*,
Tomoko Tanaka, MD*,
Tomohiro Sakamoto, MD, PhD*,
Michihiro Yoshimura, MD, PhD*,
Hideaki Jinnouchi, MD, PhD and
Hisao Ogawa, MD, PhD*
* Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
2nd Department of Internal Medicine, Interdisciplinary Graduate School of Medicine and Engineering University of Yamanashi, Yamanashi, Japan
Department of Jinnouchi Diabetes Center, Kumamoto, Japan
Manuscript received November 25, 2004;
revised manuscript received January 19, 2005,
accepted February 1, 2005.
* Reprint requests and correspondence: Dr. Seigo Sugiyama, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto City, Kumamoto, Japan 860-8556. (Email: ssugiyam{at}kumamoto-u.ac.jp).
OBJECTIVES: The purpose of this study was to examine whether CD144-EMP (endothelium-derived microparticles) is useful as a specific marker of endothelial cell (EC) dysfunction and to determine whether plasma levels of circulating CD144-EMP predicted coronary artery disease (CAD) in patients with type 2 diabetes mellitus (DM).
BACKGROUND: Endothelial cell dysfunction is involved in atherogenesis; however, the quantitative assessment of EC dysfunction has yet to be established clinically. Endothelium-derived microparticles are small, membrane-shed vesicles that are generated from the EC surface in response to cellular dysfunction and/or injury. Diabetes mellitus is known to be associated with EC dysfunction and accelerated atherosclerosis.
METHODS: We characterized EMP using anti-CD144 (VE-Cadherin) antibody in various atherosclerosis-related cells and investigated the association between the levels of CD144-positive microparticles and hydrogen-peroxide-induced EC injury and acetylcholine-induced coronary vasomotion. Furthermore, we evaluated plasma CD144-EMP levels in patients with and without DM.
RESULTS: We demonstrated that CD144-positive microparticles were derived selectively from human EC. The levels of CD144-EMP reflected the degree of in vitro hydrogen-peroxide-induced EC injury and impairment of in vivo endothelium-dependent coronary vasodilation (p < 0.01). Plasma CD144-EMP levels were increased significantly in DM patients compared with patients without DM (p < 0.001). In DM patients, the elevated levels of CD144-EMP were the most significant risk factor for CAD relative to all other traditional risk factors (odds ratio [OR] 3.5, 95% confidence interval [CI] 1.8 to 6.9, p < 0.001). Notably, plasma CD144-EMP identified a subpopulation of established CAD patients in DM subjects without typical anginal symptoms (OR 10.6, 95% CI 3.9 to 29.5, p < 0.001).
CONCLUSIONS: The CD144-positive EMP exist in human plasma, and plasma CD144-EMP levels can be a clinically specific and quantitative marker of EC dysfunction and/or injury. Measurement of CD144-EMP, by providing a quantitative assessment of EC dysfunction, may be useful for identifying DM patients with increased risk of CAD.
|
Abbreviations and Acronyms
| | ACh = acetylcholine | | CAD = coronary artery disease | | CI = confidence interval | | DM = diabetes mellitus | | EC = endothelial cells | | EMP = endothelium-derived microparticles | | FCS = fetal calf serum | | FITC = fluorescein isothiocyanate | | HAoSMC = human aortic smooth muscle cells | | HCAEC = human coronary artery endothelial cells | | HDL = high-density lipoprotein | | hs-CRP = high-sensitivity C-reactive protein | | LAD = left anterior descending coronary artery | | LDL = low-density lipoprotein | | LMT = left main trunk coronary artery | | OR = odds ratio | | PBS = phosphate-buffered saline | | sICAM-1 = soluble intercellular adhesion molecule-1 |
|
This article has been cited by other articles:
|
|
|
|
 
C Pericleous, I Giles, and A Rahman
Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?
Lupus,
July 1, 2009;
18(8):
671 - 675.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. Ayers, B. Ferry, S. Craig, D. Nicoll, J. R. Stradling, and M. Kohler
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea
Eur. Respir. J.,
March 1, 2009;
33(3):
574 - 580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Erdbruegger, M. Grossheim, B. Hertel, K. Wyss, T. Kirsch, A. Woywodt, H. Haller, and M. Haubitz
Diagnostic role of endothelial microparticles in vasculitis
Rheumatology,
December 1, 2008;
47(12):
1820 - 1825.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Amabile, C. Heiss, W. M. Real, P. Minasi, D. McGlothlin, E. J. Rame, W. Grossman, T. De Marco, and Y. Yeghiazarians
Circulating Endothelial Microparticle Levels Predict Hemodynamic Severity of Pulmonary Hypertension
Am. J. Respir. Crit. Care Med.,
June 1, 2008;
177(11):
1268 - 1275.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Heiss, N. Amabile, A. C. Lee, W. M. Real, S. F. Schick, D. Lao, M. L. Wong, S. Jahn, F. S. Angeli, P. Minasi, et al.
Brief Secondhand Smoke Exposure Depresses Endothelial Progenitor Cells Activity and Endothelial Function: Sustained Vascular Injury and Blunted Nitric Oxide Production
J. Am. Coll. Cardiol.,
May 6, 2008;
51(18):
1760 - 1771.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Tushuizen, R. Nieuwland, C. Rustemeijer, B. E. Hensgens, A. Sturk, R. J. Heine, and M. Diamant
Elevated Endothelial Microparticles Following Consecutive Meals Are Associated With Vascular Endothelial Dysfunction in Type 2 Diabetes
Diabetes Care,
March 1, 2007;
30(3):
728 - 730.
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Morel, F. Toti, B. Hugel, B. Bakouboula, L. Camoin-Jau, F. Dignat-George, and J.-M. Freyssinet
Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation?
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2006;
26(12):
2594 - 2604.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Pirro, G. Schillaci, R. Paltriccia, F. Bagaglia, C. Menecali, M. R. Mannarino, M. Capanni, A. Velardi, and E. Mannarino
Increased Ratio of CD31+/CD42- Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2006;
26(11):
2530 - 2535.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Esposito, M. Ciotola, B. Schisano, R. Gualdiero, L. Sardelli, L. Misso, G. Giannetti, and D. Giugliano
Endothelial Microparticles Correlate with Endothelial Dysfunction in Obese Women
J. Clin. Endocrinol. Metab.,
September 1, 2006;
91(9):
3676 - 3679.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
